Evidence map›Paper›PMID 39619392›Full record

ArticleJACC. Asia2024

Early Cryoablation After First Diagnosis of Atrial Fibrillation Reduces Arrhythmia Recurrence in Heart Failure Patients.

Monami Ando, Satoshi Yanagisawa, Hirohiko Suzuki, Yukihiko Yoshida, Yasunori Kanzaki, Itsuro Morishima, Shinji Ishikawa, Yosuke Kamikubo, Satoshi Okumura, Hiroyuki Kato and 15 more

Abstract read
In one paragraph

Article in JACC. Asia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Impact of catheter ablation timing according to duration of atrial fibrillation history on arrhythmia recurrences and clinical outcomes: a meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Monami AndoDepartment of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Satoshi YanagisawaDepartment of Advanced Cardiovascular Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hirohiko SuzukiDepartment of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Yukihiko YoshidaDepartment of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Yasunori KanzakiDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Itsuro MorishimaDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Shinji IshikawaDepartment of Cardiology, Cardiovascular Center, Anjo Kosei Hospital, Anjo, Japan.
Yosuke KamikuboDepartment of Cardiology, Toyota Memorial Hospital, Toyota, Japan.
Satoshi OkumuraDepartment of Cardiology, Konan Kosei Hospital, Konan, Japan.
Hiroyuki KatoDivision of Cardiology, Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Japan.
Yoshiaki MizutaniDepartment of Cardiology, Yokkaichi Municipal Hospital, Yokkaichi, Japan.
Yosuke MuraseDepartment of Cardiology, Komaki City Hospital, Komaki, Japan.
Kosuke NakasukaDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Shunichiro WaritaDepartment of Cardiology, Gifu Prefectural General Medical Center, Gifu, Japan.
Satoru SekimotoDepartment of Cardiology, Nagoya City University East Medical Center, Nagoya, Japan.
Yoshio TakemotoDepartment of Cardiology, Gifu Prefectural Tajimi Hospital, Tajimi, Japan.
Nobuhiro TakasugiDivision of Cardiovascular Medicine, Gifu University Hospital, Gifu, Japan.
Shiou OhguchiDepartment of Cardiology, Kasugai Municipal Hospital, Kasugai, Japan.
Michiharu SengaDepartment of Cardiology, Kuwana City Medical Center, Kuwana, Japan.
Kenichiro YokoiDepartment of Cardiology, Kainan Hospital, Yatomi, Japan.
Ryo WatanabeDepartment of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Yasuhiro OguraDepartment of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Rei ShibataDepartment of Advanced Cardiovascular Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yasuya IndenDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Toyoaki MuroharaDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atrial fibrillation (AF) and heart failure (HF) often coexist, leading to increased mortality. A cryoballoon-based approach is a potential treatment for patients with HF because of its safety and efficacy. Objectives: The authors sought to evaluate the optimal timing of cryoballoon ablation after the first clinical diagnosis of AF and its prognosis for patients with HF. Methods: This large-scale multicenter study retrospectively collected data of patients with HF who underwent cryoballoon ablation for AF from 17 Japanese institutions. Patients were divided into 2 groups depending on the duration between the first diagnosis and ablation using a median time of 0.5 year (IQR: 0.3-2.0 years). Clinical endpoints of recurrence, mortality, and HF hospitalization were compared between the 2 groups. Results: Among 3,655 patients, 543 with HF were included for analysis. During a median follow-up period of 21.3 months (IQR: 12.0-36.8 months), 151 of 520 patients (29%) had a recurrence. The AF recurrence rate was significantly lower in the early-ablation group (≤0.5 year) than in the delayed-ablation group (>0.5 year) (24% [65/266] vs 34% [86/254], respectively; Conclusions: Early cryoablation reduced the risk of recurrence in patients with HF, which may help improve clinical management.

Indexed as

atrial fibrillationcatheter ablationcryoballoon ablationearly ablation heart failure

Identifiers

PMID39619392
PMCPMC11604533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.